The study was published in The Journal of Bone and Joint Surgery and conducted on more than 7,000 patients undergoing the procedures at New England Baptist Hospital in Boston.
The prescreening program employed a”rapid polymerase chain reaction analysis of nasal swabs followed by an eradication protocol of intranasal mupirocin and chlorhexidine showers for identified carriers,” according to the study’s abstract.
Read the abstract of the study on prescreening staph.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.